查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983920

毒性測試外包市場：按服務供應商、測試模型和最終用戶分類－2026-2032年全球市場預測

Toxicity Testing Outsourcing Market by Service Provider, Test Model, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，毒理學測試外包市場價值將達到 47.1 億美元，到 2026 年將成長至 51.4 億美元，到 2032 年將達到 88.3 億美元，複合年成長率為 9.39%。

主要市場統計數據
基準年 2025 47.1億美元
預計年份：2026年 51.4億美元
預測年份 2032 88.3億美元
複合年成長率 (%) 9.39%

這本權威的入門書籍概述了將毒性測試外包的必要性，並提出了研發和採購部門領導者面臨的關鍵策略挑戰。

全球毒性測試外包格局正在經歷結構性和策略性的重組，這要求企業主管重新評估與供應商的關係、技術能力和合規體系。在對專業知識、可擴展的處理能力和快速排期的需求驅動下，許多機構正從純粹的內部測試模式轉向混合模式，即與學術實驗室建立合作關係並與合約研究組織 (CRO) 簽訂合約。實際上，這種轉變需要對供應商在不同測試模式下的能力進行嚴格評估，包括電腦輔助的電腦In Silico方法、靶向體外研究和成熟的體內研究，同時還要考慮倫理、監管和聲譽因素。

技術成熟度、一體化 CRO 服務模式以及與學術機構的合作如何改變毒性測試的外包模式？

外包毒性測試的格局正因技術進步、監管期望的改變以及組織優先事項的調整而重塑。計算毒理學已從一項小眾技術發展成為主流戰略工具。生理藥物動力學（PBPK）建模和定量構效關係（QSAR）方法現已常規應用於早期風險評估，從而減少了對資源密集型濕實驗室工作的依賴。同時，體外細胞毒性、遺傳毒性、內毒素和光毒性測試方法在可重複性和處理能力方面日益成熟，從而能夠更早地做出決策並簡化後續流程。伴隨這些技術變革，營運模式也正在轉變。合約研究組織（CRO）正在擴展其服務範圍，以提供整合計劃管理、集中式資料平台和統一的品質體系，從而簡化向多個司法管轄區的監管機構提交報告的流程。

評估美國於 2025 年推出的關稅變化對營運和供應鏈的影響，以及實驗室和贊助商如何適應。

美國將於2025年實施的新關稅為毒性測試供應鏈和服務交付帶來了新的複雜性。特種試劑、實驗室設備和分析耗材的進口成本增加，推高了採購成本，迫使實驗室重新評估籌資策略並實現供應商多元化。為此，許多服務供應商和學術合作夥伴正在地採購關鍵供應組件，重新談判供應商契約，探索替代材料，並簡化流程，以在保持測試完整性的同時緩解成本壓力。這些調整對計劃進度和供應商選擇標準產生了連鎖反應，促使專案發起人優先考慮那些在不影響資料品質的前提下成功實施替代材料，並已證明其供應鏈具有韌性的供應商。

將供應商類型、最終用戶行業特徵和測試模型選擇聯繫起來的關鍵細分資訊，有助於供應商選擇和項目設計。

細分市場分析揭示了不同服務提供者類型、終端用戶類別和首選檢測模型之間的微妙需求促進因素和服務期望，這些因素應指南個人商業策略。基於服務供應商，市場可細分為學術實驗室和合約研究組織 (CRO)，二者提供互補價值。學術實驗室通常主導方法創新和早期檢測檢驗，而 CRO 則提供規模化、合規營運和一體化計劃執行。從終端用戶來看，農藥、生技、化學、化妝品、食品飲料和製藥等產業的需求流各不相同。在這些產業內部，化肥製造商與農藥製造商、Start-Ups、通用化學品製造商與特種化學品製造商、彩妝品與護膚護髮產品、飲料製造商與乳製品和加工食品製造商、學名藥製造商與大型製藥公司等細分市場，影響著服務範圍、監管審查和時間表。基於檢測模型，可選擇的方案包括In Silico、體外和體內檢測。In Silico能力（包括 PBPK 和 QSAR 建模）正日益為可行性決策做出貢獻；體外試驗（如細胞毒性、內毒素、基因毒性和光毒性測試）可深入了解標靶機制；體內策略依賴替代動物模型以及非囓齒類和囓齒類模型，其中存在倫理和監管要求。

美洲、歐洲、中東和非洲以及亞太地區的營運、監管和產能趨勢，以及它們對外包策略和風險管理的影響。

區域趨勢持續對毒性測試生態系統中的營運策略、監管合規性和供應商選擇產生關鍵影響。在美洲，測試能力的集中、成熟的法規結構以及接近性主要製藥和生物技術中心的優勢，有利於快速開展臨床應用並確保測試的高合規性；然而，計劃也面臨關稅和物流波動風險，因此需要製定完善的緊急時應對計畫。在歐洲、中東和非洲，監管的多樣性和日益完善的倫理標準促進了替代模式和統一測試通訊協定的採用。同時，擁有卓越學術水平的本地研究中心為專業檢測方法的開發和合作檢驗提供了機會。在亞太地區，實驗室基礎設施的大量投資、CRO規模的擴大以及具有競爭力的成本趨勢，為外包提供了極具吸引力的選擇，尤其適用於大量測試。然而，申辦方必須謹慎應對監管預期、數據標準和供應鏈可追溯性方面的差異。

服務供應商如何透過整合科學能力、數位平台和供應鏈韌性來實現差異化，並滿足贊助商的複雜需求。

服務供應商之間的競爭格局和能力正在迅速變化，各公司正增加對專業化、數位化平台和整合服務模式的投資，以滿足申辦方日益複雜的需求。領先的合約研究組織 (CRO) 正在擴展其體外實驗組合和In Silico能力，提供結合計算科學和濕實驗室的綜合服務包，同時加強品管體系，以方便向跨國監管機構提交申請。學術實驗室正在加強與產業界的轉化夥伴關係，提供新型檢測方法和專業知識，以降低早期研發階段面臨的風險。同時，供應商在提供減少行政摩擦的服務方面也日益注重差異化，例如資料互通性、電子資料收集 (EDC) 框架以及標準化測試範本和統一報告格式。

為高階主管提供調整籌資策略、建立監督結構以及加強外包測試的供應鏈和資料管治的實用建議。

產業領導者應採取務實且優先的措施，在最大限度利用外包機會的同時，降低營運和監管風險。首先，企業應制定以細分市場主導的採購策略，將供應商的優勢與特定的最終用戶需求和測試模型要求相匹配，從而在整個產品系列中實現可重複且合理的供應商選擇。其次，企業應投資加強內部監管能力，例如提高生理藥物動力學 (PBPK) 和定量構效關係 (QSAR) 解讀能力、分析方法轉換管理能力以及合約品質指標的執行能力。這可以確保第三方夥伴關係能夠補充而非取代內部專業知識。此外，採購和研發團隊應執行嚴格的供應鏈實質審查程序，以評估試劑依賴性、單一來源風險以及應對關稅變化相關波動的緊急時應對計畫。

嚴謹、多方面的研究途徑，結合專家訪談、供應商比較和情境分析，確保提供令人信服且可操作的見解。

本研究採用多面向調查方法，結合質性專家訪談、能力比較評估和主題整合，以得出可操作的見解。主要資訊來源包括對農藥、生物技術、化工、化妝品、食品飲料和製藥等行業研發、監管和採購部門高級領導的結構化訪談，以及與學術實驗室和商業合約研究機構（CRO）的科學主任的討論。二級資訊來源包括關於檢測方法驗證和替代模型的同行評審文獻、監管指導文件和公開的企業資訊披露，從而對供應商的能力和服務產品進行多方面的檢驗。分析方法包括交叉細分映射，以將供應商類型與最終用戶需求和測試模型適用性相匹配，以及情境分析，以評估收費系統和供應鏈應急計畫。

對策略性外包、調查方法創新和供應鏈完整性如何整合以塑造未來毒性測試計劃進行綜合和總結性分析。

總之，毒性測試外包生態系統正處於一個轉折點，其特徵是技術融合、供應鏈監管加強以及申辦者期望不斷提高。計算毒理學和可靠的體外方法正在重塑早期決策，而合約研究機構 (CRO) 和學術實驗室正在演變為互補角色，可以攜手合作以加速研發並管理監管風險。關稅相關的波動增加了對供應鏈透明度和區域產能規劃的需求，促使申辦方優先選擇那些擁有成熟物流韌性和靈活採購慣例的供應商。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按服務提供者分類的毒性測試外包市場

  • 學術研究機構
  • 合約研究機構

第9章：依測試模型分類的毒性測試外包市場

  • In Silico
    • PBPK建模
    • QSAR建模
  • 體外
    • 細胞毒性試驗
    • 內毒素試驗
    • 基因毒性測試
    • 光毒性試驗
  • In vivo
    • 替代動物模型
    • 非囓齒類動物模型
    • 囓齒動物模型

第10章：毒性測試外包市場：依最終用戶分類

  • 殺蟲劑
    • 化肥生產商
    • 農業化學品製造商
  • 生物技術
    • 一家歷史悠久的生物技術公司
    • 生技新興企業
  • 化學
    • 通用化學品製造商
    • 特種化學品製造商
  • 化妝品
    • 彩妝品
    • 護髮產品
    • 護膚
  • 食品/飲料
    • 飲料製造商
    • 乳製品生產商
    • 加工食品製造商
  • 製藥
    • 學名藥
    • 大型製藥企業

第11章：毒性測試外包市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：毒性測試外包市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：毒性測試外包市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國毒理學檢測外包市場

第15章：中國毒理學檢測外包市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ALS Limited
  • Altasciences Corporation
  • BioReliance
  • Charles River Laboratories International, Inc.
  • Cyprotex
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Laboratories, Inc.
  • GenScript Biotech Corporation
  • ICON plc
  • Inotiv, Inc.
  • Intertek Group plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Parexel International Corporation
  • PAREXEL International Corporation
  • PPD, Inc.
  • Promega Corporation
  • SGS SA
  • Syngene International Limited
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-1D39DE28BC82

The Toxicity Testing Outsourcing Market was valued at USD 4.71 billion in 2025 and is projected to grow to USD 5.14 billion in 2026, with a CAGR of 9.39%, reaching USD 8.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.71 billion
Estimated Year [2026] USD 5.14 billion
Forecast Year [2032] USD 8.83 billion
CAGR (%) 9.39%

An authoritative introduction framing the outsourcing imperative in toxicity testing and the pivotal strategic questions confronting research and procurement leaders

The global environment for toxicity testing outsourcing is undergoing a structural and strategic recalibration that requires senior leaders to reassess supplier relationships, technical capabilities, and compliance postures. Many organizations are shifting away from purely internal testing paradigms toward hybrid models that mix academic laboratory partnerships and contract research organization engagements, driven by the need for specialized expertise, scalable throughput, and accelerated timelines. In practice, this transition calls for a rigorous evaluation of provider competency across diverse test models, including computational in silico approaches, targeted in vitro assays, and established in vivo studies, while also weighing ethical, regulatory, and reputational considerations.

Consequently, decision-makers must reconcile scientific rigor with commercial pragmatism. Procurement teams and R&D leaders are now defining new governance frameworks that codify quality expectations, data provenance, and cross-border operational continuity. As such, this introduction frames the critical strategic questions that follow: how to select the right mix of service providers, how to align test model choices with product development imperatives, and how to structure partnerships that preserve regulatory defensibility without sacrificing speed. This foundational perspective sets the stage for a deeper examination of the transformative shifts, tariff influences, segmentation insights, and actionable recommendations contained within the report.

How technological maturation, integrated CRO service models, and collaborative academic partnerships are reshaping the toxicity testing outsourcing paradigm

The landscape of outsourced toxicity testing is being redefined by converging technological advances, evolving regulatory expectations, and shifting organizational priorities. Computational toxicology has moved from a niche capability to a mainstream strategic lever; PBPK modeling and QSAR approaches now routinely inform early risk assessment and reduce reliance on resource-intensive wet-lab work. At the same time, in vitro methods such as cytotoxicity, genotoxicity, endotoxin, and phototoxicity testing have matured in reproducibility and throughput, enabling earlier decisions and streamlined downstream programs. These technical shifts have been paralleled by operational transformations: contract research organizations are expanding service portfolios to offer integrated project management, centralized data platforms, and harmonized quality systems that facilitate multi-jurisdictional regulatory submissions.

Moreover, academic laboratories remain an important source of niche expertise and novel assay development, often collaborating with industry to validate emergent methods. As organizations adopt blended sourcing strategies, they must also contend with talent mobility, data interoperability, and the need for standardized performance metrics. In short, the transformative shifts are not limited to technology; they encompass commercial models, data governance, and cross-sector collaborations that will determine which providers and partnerships create enduring value for sponsors.

Assessing the operational and supply chain ramifications of the United States tariff changes introduced in 2025 and how laboratories and sponsors are adapting

The introduction of new United States tariff measures in 2025 has introduced a new vector of complexity for toxicity testing supply chains and service delivery. Increased import costs for specialized reagents, laboratory instrumentation, and analytical consumables have elevated procurement spend and prompted laboratories to reassess sourcing strategies and supplier diversification. In response, many service providers and academic partners have begun to localize critical supply components, renegotiate supplier contracts, and explore alternative materials or process efficiencies to preserve test integrity while moderating cost pressures. These adjustments are having cascading effects on project timelines and vendor selection criteria, encouraging sponsors to favor providers with proven supply chain resilience and demonstrated capacity to onboard alternative inputs without compromising data quality.

In parallel, cross-border specimen and data transfer protocols have been subject to heightened scrutiny as organizations work to balance tariff-induced cost impacts with regulatory export controls and data protection requirements. As a result, sponsors are increasingly valuing end-to-end transparency in vendor logistics and contingency planning. Over time, the tariff environment has accelerated the industry's focus on vertical integration, regional laboratory expansion, and strategic inventory management, making supply chain due diligence a central component of toxicity testing outsourcing decisions.

Critical segmentation intelligence linking provider type, end-user industry nuances, and test-model selection to inform supplier selection and program design

Segmentation analysis reveals nuanced demand drivers and service expectations across provider types, end-user categories, and test-model preferences that should guide tailored commercial strategies. Based on service provider, the market is differentiated between academic laboratories and contract research organizations, with each segment delivering complementary value: academic labs frequently drive methodological innovation and early-stage assay validation, while CROs offer scale, regulated operations, and integrated project execution. Based on end user, demand flows vary across agrochemical, biotechnology, chemical, cosmetic, food and beverage, and pharmaceutical sectors; within these industries, sub-segments such as fertilizer versus pesticide manufacturers, established biotechnology firms versus start-ups, commodity versus specialty chemical producers, color cosmetics versus skin and hair care lines, beverage versus dairy and processed food manufacturers, and generic versus large pharmaceutical companies shape service scope, regulatory intensity, and timetables. Based on test model, choices span in silico, in vitro, and in vivo approaches, where in silico capabilities including PBPK and QSAR modeling increasingly inform go/no-go decisions, in vitro assays such as cytotoxicity, endotoxin, genotoxicity and phototoxicity testing provide targeted mechanistic insight, and in vivo strategies rely on alternative animal models as well as nonrodent and rodent models where ethically and regulatorily necessary.

By integrating these segmentation axes, sponsors can design sourcing strategies that align provider capabilities with product lifecycle stage, regulatory context, and risk tolerance. For instance, early-stage biotech firms often benefit from partnerships that combine academic innovation with CRO operationalization, while large pharmaceutical companies typically prioritize high-volume regulated delivery alongside advanced in silico support. Consequently, segmentation-aware supplier evaluation and contract design improve alignment between scientific needs and commercial outcomes.

Regional operational, regulatory, and capacity dynamics across the Americas, EMEA, and Asia-Pacific and their implications for outsourcing strategy and risk management

Regional dynamics continue to exert a determinative influence on operational strategy, regulatory navigation, and vendor selection in the toxicity testing ecosystem. In the Americas, capacity concentration, mature regulatory frameworks, and proximity to major pharmaceutical and biotech hubs favor rapid clinical translation and high-compliance testing, but also expose projects to tariff and logistics variability that require robust contingency plans. In Europe, the Middle East and Africa region, regulatory heterogeneity and advancing ethical standards encourage adoption of alternative models and harmonized testing protocols, while local centers of excellence in academic research offer specialized assay development and collaborative validation opportunities. In the Asia-Pacific region, significant investments in laboratory infrastructure, growing CRO scale, and competitive cost dynamics create attractive outsourcing options, particularly for high-volume testing, though sponsors must carefully manage differences in regulatory expectations, data standards, and supply chain traceability.

As organizations evaluate regional sourcing, they increasingly prioritize providers with transparent quality systems, cross-border compliance expertise, and demonstrable logistical resilience. Strategic decisions about where to place studies are therefore informed by an interplay of scientific requirements, regulatory timelines, and operational risk tolerance, making regional insight an indispensable component of vendor selection and program planning.

How service providers are differentiating through integrated scientific capabilities, digital platforms, and supply chain resilience to meet complex sponsor needs

Competitive and capability landscapes among service providers are evolving rapidly as companies invest in specialization, digital platforms, and integrated service models to meet increasingly sophisticated sponsor demands. Leading contract research organizations are expanding in vitro portfolios and in silico capabilities to offer combined computational and wet-lab packages, while also reinforcing quality management systems to facilitate multi-jurisdictional regulatory submissions. Academic laboratories are strengthening translational partnerships with industry, providing access to novel assays and specialized expertise that can de-risk early development questions. At the same time, vendor differentiation is emerging around data interoperability, electronic data capture frameworks, and offerings that reduce administrative friction, such as standardized study templates and harmonized reporting formats.

Strategic buyers should evaluate providers not only on technical performance but also on demonstrable investments in supply chain resilience, regulatory intelligence, and client-centric project governance. Partnerships with vendors who offer predictive analytics for project scheduling, validated alternative assay workflows, and transparent reagent sourcing will become increasingly valuable. In addition, collaboration models that embed knowledge transfer, capacity-building, and shared quality metrics can accelerate sponsor self-sufficiency while maintaining access to specialized capabilities when needed.

Actionable recommendations for executives to align sourcing strategies, build oversight capabilities, and strengthen supply chain and data governance in outsourced testing

Industry leaders should adopt a pragmatic, prioritized set of actions to capitalize on outsourcing opportunities while mitigating operational and regulatory risks. First, organizations should formalize a segmentation-driven sourcing playbook that maps provider strengths to specific end-user needs and test-model requirements, enabling repeatable and defensible vendor selection across product portfolios. Next, firms must invest in in-house competencies that enhance oversight-such as proficiency in PBPK and QSAR interpretation, assay transfer management, and contractual quality metrics-so that third-party partnerships complement rather than substitute internal expertise. Additionally, procurement and R&D teams should enforce stringent supply chain due diligence protocols that assess reagent dependency, single-source risks, and contingency plans in the face of tariff-driven volatility.

Furthermore, organizations should negotiate data and IP clauses that preserve analytical transparency and ensure long-term access to study outputs. They should also pilot hybrid engagement models that combine academic innovation with CRO operationalization to accelerate validation of alternative methods while maintaining regulatory robustness. Lastly, leadership should embed continuous improvement processes that track provider performance over time, incorporate learnings into subsequent study design, and refine governance structures to support scalable outsourcing across geographies and therapeutic areas.

A rigorous multi-method research approach combining expert interviews, comparative provider assessments, and scenario analysis to ensure defensible and actionable findings

This research employed a multi-pronged methodology combining qualitative expert interviews, comparative capability assessment, and thematic synthesis to produce actionable insights. Primary inputs included structured interviews with senior R&D, regulatory, and procurement leaders across agrochemical, biotechnology, chemical, cosmetic, food and beverage, and pharmaceutical sectors, as well as discussions with scientific directors from academic laboratories and commercial CROs. Secondary sources encompassed peer-reviewed literature on assay validation and alternative models, regulatory guidance documents, and publicly available company disclosures to triangulate provider capabilities and service offerings. Analytical methods included cross-segmentation mapping to align provider types with end-user requirements and test-model fit, as well as scenario analysis to evaluate tariff and supply chain contingencies.

To ensure rigor, the research applied consistent evaluation criteria across technical validity, operational scalability, regulatory readiness, and supply chain resilience. Findings were validated through iterative stakeholder feedback sessions and refined to reflect real-world constraints and best practices. This methodological approach supports reproducibility and provides a defensible basis for the strategic recommendations and segmentation insights presented in the report.

Synthesis and final reflections on how strategic outsourcing, methodological innovation, and supply chain integrity converge to shape future toxicity testing programs

In conclusion, the toxicity testing outsourcing ecosystem is at an inflection point defined by technological convergence, heightened supply chain scrutiny, and increasingly sophisticated sponsor expectations. Computational toxicology and robust in vitro methods are reshaping early decision-making, while contract research organizations and academic laboratories are evolving complementary roles that can be orchestrated to accelerate development and manage regulatory risk. Tariff-related disruptions have intensified the need for supply chain transparency and regional capability planning, prompting sponsors to prioritize vendors with demonstrated logistical resilience and adaptive sourcing practices.

Ultimately, organizations that adopt segmentation-aware sourcing, build internal oversight in critical scientific domains, and pursue strategic partnerships that blend innovation with operational rigor will be best positioned to extract value from outsourced testing. By focusing on data interoperability, validated alternative methods, and contractual frameworks that preserve access to study outputs, leaders can reduce program risk and enhance agility. The recommendations and insights provided herein offer a practical roadmap for navigating immediate challenges while building long-term resilience in toxicity testing programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Toxicity Testing Outsourcing Market, by Service Provider

  • 8.1. Academic Laboratories
  • 8.2. Contract Research Organization

9. Toxicity Testing Outsourcing Market, by Test Model

  • 9.1. In Silico
    • 9.1.1. PBPK Modeling
    • 9.1.2. QSAR Modeling
  • 9.2. In Vitro
    • 9.2.1. Cytotoxicity Testing
    • 9.2.2. Endotoxin Testing
    • 9.2.3. Genotoxicity Testing
    • 9.2.4. Phototoxicity Testing
  • 9.3. In Vivo
    • 9.3.1. Alternative Animal Models
    • 9.3.2. Nonrodent Models
    • 9.3.3. Rodent Models

10. Toxicity Testing Outsourcing Market, by End User

  • 10.1. Agrochemical
    • 10.1.1. Fertilizer Manufacturers
    • 10.1.2. Pesticide Manufacturers
  • 10.2. Biotechnology
    • 10.2.1. Established Biotechnology Firms
    • 10.2.2. Start-Up Biotechnology Firms
  • 10.3. Chemical
    • 10.3.1. Commodity Chemical Manufacturers
    • 10.3.2. Specialty Chemical Manufacturers
  • 10.4. Cosmetic
    • 10.4.1. Color Cosmetic
    • 10.4.2. Hair Care Products
    • 10.4.3. Skin Care
  • 10.5. Food And Beverage
    • 10.5.1. Beverage Manufacturers
    • 10.5.2. Dairy Product Manufacturers
    • 10.5.3. Processed Food Manufacturers
  • 10.6. Pharmaceutical
    • 10.6.1. Generic Pharma
    • 10.6.2. Large Pharma

11. Toxicity Testing Outsourcing Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Toxicity Testing Outsourcing Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Toxicity Testing Outsourcing Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Toxicity Testing Outsourcing Market

15. China Toxicity Testing Outsourcing Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. ALS Limited
  • 16.6. Altasciences Corporation
  • 16.7. BioReliance
  • 16.8. Charles River Laboratories International, Inc.
  • 16.9. Cyprotex
  • 16.10. Eurofins Scientific SE
  • 16.11. Evotec SE
  • 16.12. Frontage Laboratories, Inc.
  • 16.13. GenScript Biotech Corporation
  • 16.14. ICON plc
  • 16.15. Inotiv, Inc.
  • 16.16. Intertek Group plc
  • 16.17. IQVIA Inc.
  • 16.18. Laboratory Corporation of America Holdings
  • 16.19. Lonza Group Ltd.
  • 16.20. Parexel International Corporation
  • 16.21. PAREXEL International Corporation
  • 16.22. PPD, Inc.
  • 16.23. Promega Corporation
  • 16.24. SGS SA
  • 16.25. Syngene International Limited
  • 16.26. Toxikon Corporation
  • 16.27. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 235. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 237. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 239. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 240. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 241. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 243. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 246. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 274. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 276. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 277. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 278. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 279. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 280. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 282. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 284. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 285. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 287. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 290. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 291. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 292. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 293. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 295. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 297. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 298. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 306. UN